Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100


Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients With Co-Occurring Disorders.

Lee MT, Acevedo A, Garnick DW, Horgan CM, Panas L, Ritter GA, Campbell KM.

Psychiatr Serv. 2018 Apr 26:appips201700465. doi: 10.1176/ [Epub ahead of print]


Implementing single-item screening for drug use in a Veterans Health Administration outpatient setting.

Hodgkin D, Gao W, Merrick EL, Drebing CE, Larson MJ, Horgan CM, Sharma M, Petry NM, Saitz R.

Subst Abus. 2018 Mar 29:1-9. doi: 10.1080/08897077.2018.1449165. [Epub ahead of print]


Federal Parity and Access to Behavioral Health Care in Private Health Plans.

Hodgkin D, Horgan CM, Stewart MT, Quinn AE, Creedon TB, Reif S, Garnick DW.

Psychiatr Serv. 2018 Apr 1;69(4):396-402. doi: 10.1176/ Epub 2018 Jan 16.


Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification.

Acevedo A, Lee MT, Garnick DW, Horgan CM, Ritter GA, Panas L, Campbell K, Bean-Mortinson J.

Drug Alcohol Depend. 2018 Feb 1;183:192-200. doi: 10.1016/j.drugalcdep.2017.11.009. Epub 2017 Dec 16.


Behavioral Health Coverage Under the Affordable Care Act: What Can We Learn From Marketplace Products?

Stewart MT, Horgan CM, Hodgkin D, Creedon TB, Quinn A, Garito L, Reif S, Garnick DW.

Psychiatr Serv. 2018 Mar 1;69(3):315-321. doi: 10.1176/ Epub 2017 Dec 15.


Influencing quality of outpatient SUD care: Implementation of alerts and incentives in Washington State.

Garnick DW, Horgan CM, Acevedo A, Lee MT, Panas L, Ritter GA, Campbell K, Bean-Mortinson J.

J Subst Abuse Treat. 2017 Nov;82:93-101. doi: 10.1016/j.jsat.2017.09.007. Epub 2017 Sep 14.


Design and impact of bundled payment for detox and follow-up care.

Quinn AE, Hodgkin D, Perloff JN, Stewart MT, Brolin M, Lane N, Horgan CM.

J Subst Abuse Treat. 2017 Nov;82:113-121. doi: 10.1016/j.jsat.2017.09.012. Epub 2017 Sep 21.


The Role of Health Plans in Supporting Behavioral Health Integration.

Stewart MT, Horgan CM, Quinn AE, Garnick DW, Reif S, Creedon TB, Merrick EL.

Adm Policy Ment Health. 2017 Nov;44(6):967-977. doi: 10.1007/s10488-017-0812-3.


How Do Private Health Plans Manage Specialty Behavioral Health Treatment Entry and Continuing Care?

Quinn AE, Reif S, Merrick EL, Horgan CM, Garnick DW, Stewart MT.

Psychiatr Serv. 2017 Sep 1;68(9):931-937. doi: 10.1176/ Epub 2017 May 15.


Massachusetts Substance Use Disorder Treatment Organizations' Perspectives on the Affordable Care Act: Changes in Payment, Services, and System Design.

Quinn AE, Stewart MT, Brolin M, Horgan CM, Lane NE.

J Psychoactive Drugs. 2017 Apr-Jun;49(2):151-159. doi: 10.1080/02791072.2017.1301600. Epub 2017 Mar 28.


Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014.

Reif S, Creedon TB, Horgan CM, Stewart MT, Garnick DW.

J Psychoactive Drugs. 2017 Apr-Jun;49(2):102-110. doi: 10.1080/02791072.2017.1300360. Epub 2017 Mar 28.


How health plans promote health IT to improve behavioral health care.

Quinn AE, Reif S, Evans B, Creedon TB, Stewart MT, Garnick DW, Horgan CM.

Am J Manag Care. 2016 Dec;22(12):810-815.


Access to Addiction Pharmacotherapy in Private Health Plans.

Reif S, Horgan CM, Hodgkin D, Matteucci AM, Creedon TB, Stewart MT.

J Subst Abuse Treat. 2016 Jul;66:23-9. doi: 10.1016/j.jsat.2016.03.001. Epub 2016 Mar 14.


Behavioral Health Services in the Changing Landscape of Private Health Plans.

Horgan CM, Stewart MT, Reif S, Garnick DW, Hodgkin D, Merrick EL, Quinn AE.

Psychiatr Serv. 2016 Jun 1;67(6):622-9. doi: 10.1176/ Epub 2016 Feb 14.


Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.

Hodgkin D, Horgan CM, Creedon TB, Merrick EL, Stewart MT.

J Ment Health Policy Econ. 2015 Dec;18(4):165-73.


Testing novel patient financial incentives to increase breast cancer screening.

Merrick EL, Hodgkin D, Horgan CM, Lorenz LS, Panas L, Ritter GA, Kasuba P, Poskanzer D, Nefussy RA.

Am J Manag Care. 2015 Nov;21(11):771-9.


Health Plans' Early Response to Federal Parity Legislation for Mental Health and Addiction Services.

Horgan CM, Hodgkin D, Stewart MT, Quinn A, Merrick EL, Reif S, Garnick DW, Creedon TB.

Psychiatr Serv. 2016 Feb;67(2):162-8. doi: 10.1176/ Epub 2015 Sep 15. Erratum in: Psychiatr Serv. 2015 Nov;66(11):1241.


Private Health Plans' Contracts with Managed Behavioral Healthcare Organizations.

Garnick DW, Horgan CM, Merrick EL, Hodgkin D, Reif S, Quinn AE, Stewart M, Creedon TB.

J Behav Health Serv Res. 2017 Jan;44(1):149-157. doi: 10.1007/s11414-015-9474-7. No abstract available.


Performance measures and racial/ethnic disparities in the treatment of substance use disorders.

Acevedo A, Garnick DW, Dunigan R, Horgan CM, Ritter GA, Lee MT, Panas L, Campbell K, Haberlin K, Lambert-Wacey D, Leeper T, Reynolds M, Wright D.

J Stud Alcohol Drugs. 2015 Jan;76(1):57-67.


Management of newer medications for attention-deficit/hyperactivity disorder in commercial health plans.

Hodgkin D, Horgan CM, Quinn AE, Merrick EL, Stewart MT, Leslie LK.

Clin Ther. 2014 Dec 1;36(12):2034-2046. doi: 10.1016/j.clinthera.2014.09.019. Epub 2014 Nov 14.

Supplemental Content

Loading ...
Support Center